These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
471 related items for PubMed ID: 7681223
1. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo. Levi M, Roem D, Kamp AM, de Boer JP, Hack CE, ten Cate JW. Thromb Haemost; 1993 Feb 01; 69(2):141-6. PubMed ID: 7681223 [Abstract] [Full Text] [Related]
2. Plasminogen activation in vivo upon intravenous infusion of DDAVP. Quantitative assessment of plasmin-alpha 2-antiplasmin complex with a novel monoclonal antibody based radioimmunoassay. Levi M, de Boer JP, Roem D, ten Cate JW, Hack CE. Thromb Haemost; 1992 Jan 23; 67(1):111-6. PubMed ID: 1377412 [Abstract] [Full Text] [Related]
3. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome. Egbring R, Seitz R, Blanke H, Leititis J, Kesper HJ, Burghard R, Fuchs G, Lerch L. Behring Inst Mitt; 1986 Feb 23; (79):87-103. PubMed ID: 2424425 [Abstract] [Full Text] [Related]
4. Control of coagulation and fibrinolysis by plasma proteinase inhibitors. Travis J, Salvesen G. Behring Inst Mitt; 1983 Aug 23; (73):56-65. PubMed ID: 6206838 [Abstract] [Full Text] [Related]
5. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome. Vaziri ND, Gonzales EC, Shayestehfar B, Barton CH. J Lab Clin Med; 1994 Jul 23; 124(1):118-24. PubMed ID: 7518491 [Abstract] [Full Text] [Related]
7. Proteases and protease inhibitors in cerulein-induced acute pancreatitis in rats. Kruse P, Lasson A, Hage E. J Surg Res; 1999 Aug 06; 85(2):294-300. PubMed ID: 10423332 [Abstract] [Full Text] [Related]
8. [Study of structural features of macroglobulins complexed with plasmin]. Zhabin SG, Zorin NA, Gorin VS, Lykova OF. Vopr Med Khim; 1993 Aug 06; 39(4):53-6. PubMed ID: 8379118 [Abstract] [Full Text] [Related]
9. [Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)]. Matsuda T, Seki T, Miura R, Ogawara M, Yokouchi M, Yamanouchi H. Rinsho Byori; 1980 Mar 06; 28(3):261-4. PubMed ID: 6154815 [No Abstract] [Full Text] [Related]
10. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus. Glas-Greenwalt P, Kant KS, Allen C, Pollak VE. J Lab Clin Med; 1984 Dec 06; 104(6):962-76. PubMed ID: 6239000 [Abstract] [Full Text] [Related]
11. Changes in plasma levels of protease and fibrinolytic inhibitors induced by treatment in acute myeloid leukemia. Velasco F, Torres A, Andres P, Martinez F, Gomez P. Thromb Haemost; 1984 Aug 31; 52(1):81-4. PubMed ID: 6238445 [Abstract] [Full Text] [Related]
12. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation. Scully MF, Toh CH, Hoogendoorn H, Manuel RP, Nesheim ME, Solymoss S, Giles AR. Thromb Haemost; 1993 May 03; 69(5):448-53. PubMed ID: 7686692 [Abstract] [Full Text] [Related]